LIVN(LivaNova PLC) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.04B | $1.02B | $1.15B | $1.25B | $1.39B |
| 毛利润 | $705.99M | $707.23M | $755.82M | $853.48M | $939.87M |
| 营业利润 | −$784.00K | −$76.75M | −$68.50M | $129.05M | $199.39M |
| 净利润 | −$135.82M | −$86.25M | $17.55M | $63.23M | −$242.47M |
| 经营现金流 | $102.54M | $69.92M | $74.91M | $183.04M | $254.34M |
| 自由现金流 | $77.07M | $43.40M | $39.93M | $135.93M | $173.29M |
| 摊薄每股收益 | $-2.68 | $-1.61 | $0.32 | $1.16 | $-4.45 |